HC Wainwright reiterated their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a $50.00 target price on the biotechnology company’s stock. Other analysts have also recently issued reports about the stock. Stephens initiated coverage on shares of Actinium Pharmaceuticals […]
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Stock analysts at Cantor Fitzgerald boosted their FY2024 earnings estimates for shares of Actinium Pharmaceuticals in a report released on Tuesday, April 30th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biotechnology company will post earnings of ($1.35) per share for the year, up from their […]
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,980,000 shares, a drop of 9.6% from the March 31st total of 2,190,000 shares. Based on an average daily volume of 354,100 shares, the days-to-cover ratio […]
Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Shares Down 7.1% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have been given a consensus recommendation of “Buy” by the five ratings firms that are currently covering the company, Marketbeat Ratings reports. Five analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on […]
Actinium Pharmaceuticals' (ATNM) Buy Rating Reaffirmed at HC Wainwright theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Equities researchers at William Blair decreased their Q3 2023 earnings per share estimates for shares of Actinium Pharmaceuticals in a report released on Tuesday, August 15th. William Blair analyst A. Hsieh now forecasts that the biotechnology company will post earnings of ($0.73) per share for the quarter, […]
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Free Report) – Stock analysts at HC Wainwright raised their Q3 2023 earnings estimates for shares of Actinium Pharmaceuticals in a research note issued to investors on Tuesday, August 15th. HC Wainwright analyst J. Pantginis now expects that the biotechnology company will earn ($0.39) per share for the quarter, up […]
Equities researchers at StockNews.com began coverage on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Get Rating) in a research note issued to investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other research firms have also commented on ATNM. Cantor Fitzgerald raised their price target on Actinium Pharmaceuticals […]
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Rating) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totalling 1,320,000 shares, a decrease of 27.5% from the April 15th total of 1,820,000 shares. Based on an average daily trading volume, of 392,900 shares, the days-to-cover ratio […]